CV Sciences Inc (CVSI)

[Wolf-man jack]

7 and 11 o’clock news brought to you by Brother Brevin from the CVSY channel. Have Mercy Wolf ahooooooo

Wells Fargo: C-Stores “Advantaged to Win” With CBD Products
https://www.nosh.com/news/2019/wells-fargo-c-stores-advantaged-to-win-with-cbd-products

Convenience stores are positioned to be a top retail channel for CBD products, according to a new survey of c-store retailers by Wells Fargo Securities.

With Constellation Brands CEO Bill Newlands saying earlier this summer that he expected the global cannabis and CBD market to reach over $200 billion by 2032 — and the United States currently driving about 90% of this growth — CBD products could prove to be a lucrative offering for c-stores as legal markets develop. Wells Fargo analysts surveyed c-store owners representing approximately 70,000 stores and found that retailers are largely positive about the opportunity to sell CBD products in-store, and see high levels of consumer interest despite current regulatory restrictions.


UK NHS Says Epidiolex Too Expensive, GW Pharma Says Company 'Remains Hopeful'

https://www.benzinga.com/node/14346502

GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH)'s CBD drug Epidiolex, which treats epilepsy, has been deemed too expensive by the U.K.’s National Health Service, according to an iNEWS report.

Epidiolex has been shown to be effective in limiting seizures in children with rare forms of epilepsy, but the U.K.’s medical advisory board has ruled that its price is cost-prohibitive for the national program.